- Vero Biotech LLC, an Atlanta, Georgia-based biotechnology company, closed a senior secured term loan of $50m
- Runway Growth Capital provided the financing
- Vero Biotech (formerly known as GeNO LLC), a biotechnology company focused on the design, development, and commercialization of next-generation products
- The company also developed the GENOSYL® Delivery System (GENOSYL DS), a inhaled nitric oxide delivery system approved by the U.S. Food and Drug Administration (FDA)
- The GENOSYL DS transforms the delivery and use of nitric oxide, a vasodilator proven to play a critical role in the care of patients with adult respiratory distress syndrome
- The GENOSYL® Delivery System authorized by the U.S. FDA for expanded emergency use access for patients with cardiopulmonary complications
Vero Biotech: Secures $50M in Funding
